Wondering why Cyltezo Pen 40 Mg/0.4 Ml Starter Pack is so hard to find in 2026? Learn the reasons behind limited availability and what you can do about it.
If you've been prescribed Cyltezo Pen 40 Mg/0.4 Ml Starter Pack and your pharmacy says they don't have it in stock, you're not alone. Many patients across the country are running into the same frustrating problem. The good news is that there are real reasons behind this — and real steps you can take to get your medication.
In this article, we'll break down exactly what Cyltezo is, why it's so difficult to find, and what your options are in 2026.
Cyltezo is the brand name for adalimumab-dbll, a biologic medication made by Boehringer Ingelheim. It's an FDA-approved interchangeable biosimilar to Humira (adalimumab), which means it works the same way and can be substituted at the pharmacy level in many states without needing a new prescription from your doctor.
Cyltezo is a TNF-alpha inhibitor. It works by blocking a protein in your body called tumor necrosis factor-alpha (TNF-α) that causes inflammation. It's used to treat a range of autoimmune conditions, including:
The Starter Pack is designed for patients beginning treatment. It comes as a prefilled pen for subcutaneous injection — a citrate-free formula with a 29-gauge needle designed for less injection pain.
There are several overlapping reasons why this medication can be tough to locate at your local pharmacy. Here are the main ones:
Cyltezo is classified as a specialty medication. Unlike common prescriptions that every CVS or Walgreens carries, specialty drugs are typically distributed through a network of specialty pharmacies. These pharmacies have the cold-chain storage and handling capabilities required for biologic medications.
This means your neighborhood retail pharmacy likely does not stock Cyltezo — and may not even be able to order it through their regular distributors. Most patients receive Cyltezo through mail-order specialty pharmacies or through their doctor's office.
Pharmacy benefit managers (PBMs) play a huge role in which drugs are available to you. Many PBMs have negotiated exclusive contracts with specific adalimumab biosimilar manufacturers. If your PBM has contracted with a competitor like Amjevita or Hadlima, Cyltezo may not be on your plan's preferred formulary — making it harder to fill even if a pharmacy could stock it.
These formulary decisions are driven by rebates and pricing negotiations, not by clinical differences between the biosimilars.
Since Humira's patent exclusivity ended, multiple adalimumab biosimilars have entered the market. As of 2026, there are numerous options including Amjevita, Hadlima, Hyrimoz, Yusimry, and Simlandi, among others. This intense competition means pharmacies and health plans may only carry one or two preferred options rather than stocking all of them.
Cyltezo was actually the first adalimumab biosimilar approved by the FDA back in 2017 and the first to receive interchangeable status. However, market share has been fragmented across many competitors.
As a biologic, Cyltezo must be kept refrigerated between 36°F and 46°F (2°C to 8°C). This cold-chain requirement adds complexity to stocking and shipping. Pharmacies that don't regularly handle biologics may be reluctant to stock a product that requires specialized storage and has limited demand at their specific location.
Don't give up. There are several practical steps you can take right now:
Medfinder lets you search for pharmacies that currently have your medication in stock. Instead of calling pharmacy after pharmacy, you can check availability online and find a location near you — or a mail-order option — that has Cyltezo ready to dispense.
Your prescriber's office likely has relationships with specialty pharmacies. Ask them to send your prescription directly to a specialty pharmacy that stocks Cyltezo. Many specialty pharmacies will ship directly to your home with free overnight delivery.
The manufacturer offers patient support programs that can help connect you with pharmacies that carry Cyltezo. They may also offer copay assistance — learn more in our guide on how to save money on Cyltezo.
Independent pharmacies sometimes have more flexibility in ordering specialty medications than large chain pharmacies. It's worth calling a few in your area. For more tips, see our article on how to find Cyltezo in stock near you.
If Cyltezo simply isn't available through your insurance or pharmacy network, your doctor may be able to prescribe a different adalimumab biosimilar that your plan covers. Since these are all biosimilar to Humira, switching is generally straightforward. Read more in our post on alternatives to Cyltezo.
Finding Cyltezo Pen 40 Mg/0.4 Ml Starter Pack can be frustrating, but the difficulty isn't because the drug is discontinued or unsafe. It comes down to the way specialty medications are distributed, how insurance formularies work, and the crowded biosimilar marketplace.
The most important thing is to not let a stock issue delay your treatment. Use tools like Medfinder, talk to your doctor about specialty pharmacy options, and explore alternatives if needed. Your health comes first.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
